Arthritis Innovation Corporation

Canada
Toronto, Ontario, Canada, M1N1B1

Company profile

Arthritis Innovation Corporation company profile

Arthritis Innovation Corporation (AIC) is a development stage company addressing unmet needs in Orthopedic Surgery and Arthritis management. A private company founded in 2013, AIC is partnered with MedinCell (www.medincell.com), and leverages a world-class product development team in Toronto, Canada with MedinCell's proprietary polymer platform technology. The Company's first product under aggressive development is intended for the management of pain and inflammation following total knee replacement (TKR) through sustained local delivery of a marketed NSAID, as an alternative to oral NSAIDs or narcotics.

Business identity

Phone number
416-844-5133
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0+
Founded
2013-01-01

Headquarters

Postal code
M1N1B1
Country code
CA
Continent
North America

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
1
Total equity funding
$324,350
Last funding
Seed / $324,350 / 2017-02-09
Last equity funding
Seed / $324,350
Founders
1
Articles
5

Founders and investors

Founders

Wayne Marshall